However, there were no significant differences among OLFM4, XIST, TSIX, KDM5D, and RPS4Y1 levels between BA patients and healthy children; hence, we chose SPON2 to conduct the following experiments. This evidence concerns the gene RPS4Y1 and breast angiosarcoma.